Revisiting fibrosis in inflammatory bowel disease: the gut thickens

S D'Alessio, F Ungaro, D Noviello, S Lovisa… - Nature Reviews …, 2022 - nature.com
Intestinal fibrosis, which is usually the consequence of chronic inflammation, is a common
complication of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative …

Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases

F Rieder, C Fiocchi, G Rogler - Gastroenterology, 2017 - Elsevier
In the last 10 years, we have learned much about the pathogenesis, diagnosis, and
management of intestinal fibrosis in patients with inflammatory bowel diseases. Just a …

The charming world of the extracellular matrix: a dynamic and protective network of the intestinal wall

S Pompili, G Latella, E Gaudio, R Sferra… - Frontiers in …, 2021 - frontiersin.org
The intestinal extracellular matrix (ECM) represents a complex network of proteins that not
only forms a support structure for resident cells but also interacts closely with them by …

Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation

K Scheibe, C Kersten, A Schmied, M Vieth, T Primbs… - Gastroenterology, 2019 - Elsevier
Background & Aims Intestinal fibrosis is a long-term complication in inflammatory bowel
diseases (IBD) that frequently results in functional damage, bowel obstruction, and surgery …

Immunology of inflammatory bowel disease: molecular mechanisms and therapeutics

Q Lu, M Yang, Y Liang, J Xu, H Xu, Y Nie… - Journal of …, 2022 - Taylor & Francis
As a main digestive organ and an important immune organ, the intestine plays a vital role in
resisting the invasion of potential pathogens into the body. Intestinal immune dysfunction …

Fibrosis related inflammatory mediators: role of the IL‐10 cytokine family

E Sziksz, D Pap, R Lippai, NJ Béres… - Mediators of …, 2015 - Wiley Online Library
Importance of chronic fibroproliferative diseases (FDs) including pulmonary fibrosis, chronic
kidney diseases, inflammatory bowel disease, and cardiovascular or liver fibrosis is rapidly …

ROS in gastrointestinal inflammation: rescue or sabotage?

G Aviello, UG Knaus - British journal of pharmacology, 2017 - Wiley Online Library
The intestine is composed of many distinct cell types that respond to commensal microbiota
or pathogens with immune tolerance and proinflammatory signals respectively. ROS …

Exosome‐mediated effects and applications in inflammatory bowel disease

DKW Ocansey, L Zhang, Y Wang, Y Yan… - Biological …, 2020 - Wiley Online Library
Gut mucosal barriers, including chemical and physical barriers, spatially separate the gut
microbiota from the host immune system to prevent unwanted immune responses that could …

CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis

X Wu, L Qian, H Zhao, W Lei, Y Liu, X Xu, J Li… - Ageing research …, 2023 - Elsevier
Fibrosis is a pathological process caused by abnormal wound healing response, which
often leads to excessive deposition of extracellular matrix, distortion of organ architecture …

[HTML][HTML] Succinate receptor mediates intestinal inflammation and fibrosis

DC Macias-Ceja, D Ortiz-Masiá, P Salvador… - Mucosal …, 2019 - Elsevier
Succinate, an intermediate of the tricarboxylic acid cycle, is accumulated in inflamed areas
and its signaling through succinate receptor (SUCNR1) regulates immune function. We …